Connect with Sona

  •  

Email: info@sonanano.com

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Latest News

Sona Develops Rapid Screening Test for Coronavirus

  HALIFAX, Feb 10, 2020 — Sona Nanotech Inc. (“Sona”) (CSE: SONA) is deploying its proprietary nanotechnology in the development of a rapid screening test for the current Coronavirus, “nCoV19”. Sona is developing a quick-response lateral-flow test to screen patients … Read More

Read More

Sona announces key partner for Coronavirus Rapid Screening Test

Halifax, Nova Scotia, Feb. 13, 2020 – Sona Nanotech Inc. (“Sona”) (CSE: SONA) has secured an agreement with The Native Antigen Company (“Native”) to supply biologics for the recently announced Covid-19 Coronavirus rapid screening test, currently in development by Sona … Read More

Read More

We produce high-quality gold nanorod products for diagnostic tests & medical treatment applications

Sona's unique gold nanorods will power the next generation of lateral flow diagnostics

THE SONA ADVANTAGE

SonaCast - our all new podcast - is out now!
Subscribe on your favourite podcast platform.

Lateral Flow Diagnostic Applications

Food & Beverage

Medical Diagnostics

Environmental Testing

Consumer Health & Pharmaceuticals

Drugs of Abuse

Military

Animal
Diagnostics

LATERAL FLOW TEST =
IMMEDIATE PATIENT FEEDBACK

Lateral flow tests powered by Sona’s unique gold nanorods can give results within minutes.

Sona’s multi-coloured gold nanorods allow for multiple test lines per unit, with easy-to-read results  from one small sample. 

Advantages of Sona's Nanorod Technology

  • Allows one test to detect multiple conditions​
  • Allows one test to maximize use from a small sample
  • Allows one test to detect multiple analyses for specific conditions
  • Individual, distinct colours for quantification measurement
  • Generates amplified visual signals for simpler interpretation
  • Generates increased sensitivity, specificity & time to results
  • Sona nanorods have a longer shelf life and resistance to hot temperatures than current technology
  • Non toxic – CTAB free

Comprehensive suite of products and services for multiple applications

• Gold nanorods
• Custom conjugation
• Lateral flow test development
• Lateral flow test production

PRODUCTS & SERVICES

• Point of care diagnostics
• Drug delivery
• Photothermal therapy
• Cell imaging

APPLICATIONS

Praise for Sona's technology from businesses and academics

   “I am very optimistic about the future of Sona; the gold nanorods they make are very versatile, with huge application potential in various fields.”

Dr Shine Xu Zhang

Industrial research chair in  applied nanotechnology,  Cape Breton University

  “Gold nanorods that have been synthesized and stabilized without CTAB are obviously a safer alternative. The fact that such a particle is commercially available today is astonishing. This could be a very important step forward for a number of promising clinical methods.”

Dr Catherine J. Murphy

Gold nanorod pioneer, professor of chemistry, Department of Chemistry, University of Illinois

“Sona’s unique gold nanotechnology is very impressive and has the potential to transform lateral flow. We are proud to partner with such an innovative company and we know that together Sona and Bond can achieve great things.”

Phil Groom

Commercial Director, Bond Digital Health

Upcoming events

Meet members of Team Sona and learn more about our technology, products and services at these upcoming events:

• Advanced Lateral Flow Course, 22-24 October 2019, San Diego, CA, USA

To arrange a meeting or learn more, get in touch.

CONTACT US

Latest News

Sona Announces Data Partnership for Covid-19 Rapid Screening Test

Halifax, Nova Scotia, February 18, 2020 – Sona Nanotech Inc. (CSE: SONA) has announced a partnership with UK-based medical technology company Bond Digital Health (Bond) to add data capture and analysis to its coronavirus (Covid-19) rapid screening test currently in development. This data partnership will allow test result data to be collected through either a reader system or mobile app before being securely stored in the cloud. The data can be accessed and analysed on an analytics dashboard, providing feedback on: The total number of tests administered Positive and negative results Geolocation of where tests are administered Demographic information of

Read More »
February 18, 2020
SONA NEWS

Latest Blog Post
Blog

The lateral flow market in 2020

The worldwide lateral flow market is large, and growing rapidly, with more than 2 billion tests produced every year. Worth an estimated $6 billion (US) in 2018, the market is projected to reach $8.7 billion (US) in 2023. In this blog Sona CEO Darren Rowles takes a look at the market and what 2020 might bring.   What is the current state of the market and how might this change in 2020?   Whichever market segment you look at, for example human health, animal health or agriculture, lateral flow is an in-demand technology. Professionals working in these sectors want quick

Read More »
November 28, 2019
SONA BLOG
Sona_Nanotech_Logo_H
Subscribe to the Sona Newsletter
Linkedin-in Twitter Youtube Instagram Facebook

Privacy Policy